 Regeneron Pharmaceuticals, Inc. NASDAQ:REGN ESMO 2022 Investor Event September 12, 2022 8:00 AM ET Company Participants Ryan Crowe - Head, IR David Weinreich - EVP, Global Clinical Development Israel Lowy - SVP, Translational Sciences Oncology Justin Holko - VP, Global Commercial Business Unit Conference Call Participants Brian Abrahams - RBC Christopher Raymond - Piper Sandler David Risinger - SVB Securities Evan Seigerman - BMO Justin Burns - Barclays Mohit Bansal - Wells Fargo Robyn Karnauskas - Truist Salveen Richter - Goldman Sachs Tyler Van Buren - Cowen Yatin Suneja - Guggenheim Partners Operator Good day, and thank you for standing by. Welcome to the Regeneron ESMO 2022 Investor Event. 